Equity Overview
Price & Market Data
Price: $15.90
Daily Change: +$0.03 / 0.19%
Daily Range: $15.66 - $16.21
Market Cap: $11,866,414,080
Daily Volume: 2,446,726
Performance Metrics
1 Week: 8.95%
1 Month: -5.40%
3 Months: -5.18%
6 Months: -38.38%
1 Year: -30.88%
YTD: -8.86%
Company Details
Employees: 159
Sector: Health technology
Industry: Biotechnology
Country:
Details
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.